Camtek Ltd. (CAMT) Is At $6.86 Formed Wedge; 11 Analysts Bullish Nevro Corp. (NVRO)

Camtek Ltd. (NASDAQ:CAMT) Logo

Camtek Ltd. (CAMT) formed wedge up with $7.20 target or 5.00% above today’s $6.86 share price. Camtek Ltd. (CAMT) has $246.49M valuation. The stock increased 0.15% or $0.01 during the last trading session, reaching $6.86. About 79,332 shares traded. Camtek Ltd. (NASDAQ:CAMT) has risen 83.78% since April 26, 2017 and is uptrending. It has outperformed by 72.23% the S&P500.

Among 14 analysts covering Nevro Corp (NYSE:NVRO), 11 have Buy rating, 1 Sell and 2 Hold. Therefore 79% are positive. Nevro Corp had 34 analyst reports since August 13, 2015 according to SRatingsIntel. Leerink Swann maintained it with “Outperform” rating and $110 target in Tuesday, November 7 report. The stock of Nevro Corp. (NYSE:NVRO) has “Buy” rating given on Thursday, July 6 by Northland Capital. The stock of Nevro Corp. (NYSE:NVRO) has “Buy” rating given on Thursday, April 12 by Canaccord Genuity. The rating was initiated by BMO Capital Markets with “Outperform” on Friday, September 25. The firm earned “Buy” rating on Tuesday, December 12 by BMO Capital Markets. ValuEngine downgraded the stock to “Sell” rating in Thursday, May 25 report. On Tuesday, January 23 the stock rating was maintained by William Blair with “Buy”. The stock of Nevro Corp. (NYSE:NVRO) earned “Buy” rating by Canaccord Genuity on Thursday, March 23. Canaccord Genuity maintained the stock with “Buy” rating in Sunday, October 8 report. The stock has “Overweight” rating by Piperjaffray on Friday, July 22. See Nevro Corp. (NYSE:NVRO) latest ratings:

12/04/2018 Broker: Canaccord Genuity Rating: Buy New Target: $110.0000 Maintain
04/04/2018 Broker: Goldman Sachs Rating: Neutral New Target: $83 Initiates Coverage On
22/02/2018 Broker: Canaccord Genuity Rating: Buy New Target: $110.0 Maintain
23/01/2018 Broker: William Blair Rating: Buy Maintain
16/01/2018 Broker: Canaccord Genuity Rating: Buy New Target: $110.0 Maintain
12/12/2017 Broker: BMO Capital Markets Rating: Buy New Target: $100.0 Maintain
07/11/2017 Broker: Leerink Swann Rating: Outperform Old Target: $105 New Target: $110 Maintain
07/11/2017 Broker: Canaccord Genuity Rating: Buy Old Target: $120 New Target: $110 Maintain

Among 6 analysts covering Camtek Ltd (NASDAQ:CAMT), 6 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Camtek Ltd had 16 analyst reports since July 27, 2015 according to SRatingsIntel. Zacks upgraded the shares of CAMT in report on Thursday, August 6 to “Hold” rating. The firm has “Buy” rating by Needham given on Monday, July 27. As per Monday, April 9, the company rating was initiated by Northland Capital. The rating was maintained by Chardan Capital Markets on Thursday, July 30 with “Buy”. Needham maintained the stock with “Buy” rating in Wednesday, February 7 report. Needham upgraded the shares of CAMT in report on Tuesday, October 3 to “Buy” rating. The company was maintained on Friday, July 21 by B. Riley & Co. The rating was maintained by B. Riley & Co with “Buy” on Thursday, August 3. The rating was maintained by Needham on Friday, July 22 with “Buy”. On Thursday, February 8 the stock rating was maintained by B. Riley & Co with “Buy”.

Analysts await Camtek Ltd. (NASDAQ:CAMT) to report earnings on May, 8. They expect $0.11 earnings per share, up 22.22% or $0.02 from last year’s $0.09 per share. CAMT’s profit will be $3.95M for 15.59 P/E if the $0.11 EPS becomes a reality. After $0.09 actual earnings per share reported by Camtek Ltd. for the previous quarter, Wall Street now forecasts 22.22% EPS growth.

The stock decreased 1.21% or $1.07 during the last trading session, reaching $87.72. About 333,786 shares traded or 11.00% up from the average. Nevro Corp. (NYSE:NVRO) has declined 8.11% since April 26, 2017 and is downtrending. It has underperformed by 19.66% the S&P500.

Camtek Ltd. (NASDAQ:CAMT) Ratings Chart